HomeNewsBusinessCompaniesCoronavirus pandemic | Recruitment firms stare at bleak future due to freeze in hiring activity

Coronavirus pandemic | Recruitment firms stare at bleak future due to freeze in hiring activity

Recruitment consultants told Moneycontrol that while a few companies have adopted technology to hire people, rest have put hiring plans on the backburner.

March 26, 2020 / 13:54 IST
Story continues below Advertisement

At a Bengaluru-based recruitment firm, the past two weeks have only been about cancellations of interviews from clients in the wake of the coronavirus outbreak. As a result of the 21-day lockdown announced by Prime Minister Narendra Modi to contain the spread, hiring activities have come to a halt.

"There will be a minimum 50 percent dip in hiring in March and April and this will have a direct impact on our revenue," said the chief executive of a firm.

Story continues below Advertisement

March and April are among the busiest periods for recruitment firms since companies hire talent for the new financial year. However, now corporates have told employees to avail work-from-home facility for non-essential services. Hence, hiring activities have also been delayed.

Track this blog for latest updates on coronavirus outbreak

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show